Chengfang, Xu

?

Titles

- Vice professor

- Master Supervisor

?

Research Interests

Fetal Medicine: prenatal screening and diagnosis

Pregnancy Complicated with various Liver Disease: Pregnancy with chronic hepatitis B infection, acute fatty liver of pregnancy, liver function failure during pregnancy

Prediction and management of abortion and preterm labor hypertensive disorders in pregnancy

Critical care in pregnancy

Antepartum fetal and maternal surveillance and intrapartum surveillance.

?

Education and Experience

EDUCATION

September 1994 - July 1999，Sun Yet-sen University of Medical Science，Clinical Department，undergraduate course

September 1999 - July 2001，the Third Affiliated Hospital of Zhongshan University, Obstetrics and gynecology Department, master of seven-year program, supervisor: professor xiao-mao Li

September 2007 - July 2011，the Third Affiliated Hospital of Zhongshan University, Obstetrics and gynecology Department, Ph. D, Tutor: professor xiao-mao Li

WORK EXPERIENCES

September 2001 - July 2004 ， the Third Affiliated Hospital of Zhongshan University, Obstetrics and gynecology Department , resident doctor

August 2004 - December 2011 ，the Third Affiliated Hospital of Zhongshan University, Obstetrics and gynecology Department, visiting staff

January 2012 till now ，the Third Affiliated Hospital of Zhongshan University, Obstetrics and gynecology Department, vice professor

?

Funds in recent 3 years：

2013, Natural Fund Project of Guangdong Province (S2013010016435) ，project name: Study of PTEN gene in the combination therapy of? paclitaxel and PI3K/AKT inhibitors in endometrial cancer;

2016, Guangdong Provincial Industrial Technology Research and Development Special Fund Project(20160915), project name: Study of? mesenchymal stem cells mediated by ARRB1 PI3K pathways for the repair of pregnancy liver damage .

2017, Guangzhou science and technology plan projects　(201704020170), Estrogen/progestogen regulate pregnancy liver damage by ARRBS mediated PI3K/AKT signaling pathway.

?

Publications in recent 3 years：

1.????? GJIC Enhances the Photo toxxicity of Photofrin-mediated Photodynamic treatment by the mechanisms related with ROS and Calcium pathways. Journal of BIOPHOTONICS, 2015,1002(10),1-10；

2、?? β-Arrestin1 inhibits chemotherapy-induced intestinal stem cell apoptosis and mucositis CELL DEATH AND DISEASE ,2016. 7；

3、?? Combination Effects of Paclitaxel with Signaling Inhibitors in Endometrial Cancer Cells. ASIAN PACIFI J CANCER PREV, 12, 2951-2957；

4、?? High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinoma. Therapeutics and Clinical Risk Management. 2017:13 279–285

5、?? Hypoxia-induced activation of the JAK/STAT3 signaling pathway promotes trophoblast cell viability and angiogenesis in preeclampsia. Medical science monitor，2017; 23

6、Cx32 inhibits TNFα-induced extrinsic apoptosis with and without EGFR suppression. Oncology Reports, 2017;5950

?

Contact

Department of Obstetrics, the Third Affiliated Hospital of Sun Yat-Sen University

Tianhe Road NO. 600

Guangzhou, Guangdong, China, 510630

Appointment Phone: 020-85252172

Email: lindaxu2011@qq.com

?